DaVita (NYSE:DVA) Reaches New 12-Month High – What’s Next?

DaVita Inc. (NYSE:DVA)’s share price reached a new 52-week high on Tuesday . The stock traded as high as $240.07 and last traded at $240.1660, with a volume of 46619 shares changing hands. The stock had previously closed at $236.31.

Analysts Set New Price Targets

DVA has been the subject of a number of research analyst reports. Barclays boosted their price objective on DaVita from $194.00 to $218.00 and gave the stock an “equal weight” rating in a report on Wednesday, July 8th. Deutsche Bank Aktiengesellschaft upgraded DaVita from a “hold” rating to a “buy” rating and increased their target price for the stock from $126.00 to $220.00 in a research note on Wednesday, May 6th. Zacks Research downgraded DaVita from a “strong-buy” rating to a “hold” rating in a research note on Monday, July 6th. Weiss Ratings reaffirmed a “hold (c+)” rating on shares of DaVita in a report on Monday, June 8th. Finally, UBS Group increased their price objective on DaVita from $235.00 to $270.00 and gave the stock a “buy” rating in a research report on Friday, July 10th. Two analysts have rated the stock with a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock presently has a consensus rating of “Hold” and a consensus target price of $216.50.

DaVita Trading Up 1.5%

The stock’s 50-day simple moving average is $214.34 and its 200-day simple moving average is $169.95. The stock has a market cap of $15.39 billion, a price-to-earnings ratio of 22.24, a price-to-earnings-growth ratio of 0.77 and a beta of 0.88.

DaVita (NYSE:DVA) last issued its quarterly earnings results on Tuesday, May 5th. The company reported $2.87 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.33 by $0.54. The business had revenue of $3.42 billion during the quarter, compared to analysts’ expectations of $3.36 billion. DaVita had a negative return on equity of 270.37% and a net margin of 5.65%.The firm’s revenue for the quarter was up 6.0% compared to the same quarter last year. During the same period in the previous year, the company posted $2.00 earnings per share. DaVita has set its FY 2026 guidance at 14.100-15.200 EPS. On average, equities research analysts forecast that DaVita Inc. will post 15.07 earnings per share for the current year.

Insider Buying and Selling at DaVita

In other news, insider Kathleen Alyce Waters sold 15,405 shares of the company’s stock in a transaction on Monday, June 15th. The stock was sold at an average price of $208.40, for a total transaction of $3,210,402.00. Following the completion of the sale, the insider directly owned 109,194 shares in the company, valued at approximately $22,756,029.60. This represents a 12.36% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CFO Joel Ackerman sold 51,471 shares of the stock in a transaction on Thursday, May 7th. The stock was sold at an average price of $192.10, for a total value of $9,887,579.10. Following the sale, the chief financial officer directly owned 132,434 shares in the company, valued at approximately $25,440,571.40. This trade represents a 27.99% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. 1.90% of the stock is owned by insiders.

Institutional Investors Weigh In On DaVita

A number of large investors have recently bought and sold shares of the company. Root Financial Partners LLC lifted its holdings in shares of DaVita by 128.0% during the 1st quarter. Root Financial Partners LLC now owns 187 shares of the company’s stock worth $29,000 after acquiring an additional 105 shares during the period. Caitlin John LLC bought a new position in DaVita in the fourth quarter valued at approximately $34,000. Sankala Group LLC acquired a new position in DaVita during the fourth quarter valued at approximately $39,000. Canada Pension Plan Investment Board bought a new stake in DaVita during the second quarter worth $43,000. Finally, Kestra Advisory Services LLC bought a new stake in DaVita during the fourth quarter worth $45,000. 90.12% of the stock is currently owned by institutional investors and hedge funds.

DaVita Company Profile

DaVita Inc (NYSE: DVA) is a leading provider of kidney care services, specializing in the management and operation of outpatient dialysis centers for patients with chronic kidney failure and end-stage renal disease. Headquartered in Denver, Colorado, the company offers a comprehensive suite of treatment modalities, including in-center hemodialysis, peritoneal dialysis, and home dialysis therapies. In addition to its core dialysis services, DaVita provides patient education, nutritional counseling, vascular access management and related laboratory services to support kidney health and overall patient well-being.

Since its formation in the mid-1990s through a clinical management services spin-off, DaVita has expanded both organically and through strategic partnerships and acquisitions.